Sage Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 02, 2022 at 07:21 am EDT
Sage Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 126.26 million compared to USD 107.25 million a year ago. Basic loss per share from continuing operations was USD 2.13 compared to USD 1.83 a year ago. Diluted loss per share from continuing operations was USD 2.13 compared to USD 1.83 a year ago.
For the six months, net loss was USD 248.32 million compared to USD 203.01 million a year ago. Basic loss per share from continuing operations was USD 4.2 compared to USD 3.47 a year ago. Diluted loss per share from continuing operations was USD 4.2 compared to USD 3.47 a year ago.